Stock listing
Tanvex Biopharma, Inc.
Selected listing: 6541 · TWSE · TWD · TW
Tanvex Biopharma, Inc. (TWSE:6541), Health Technology. Latest release Aug 15, 2022: Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc.…
- Ticker
- TWSE:6541
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TWSE
- Currency
- TWD
About Tanvex Biopharma, Inc.
Tanvex Biopharma, Inc. is a publicly traded company on the Taiwan market under the ticker 6541. Tanvex focuses on biopharmaceutical development, contributing to advancements in healthcare.
Latest news from Tanvex Biopharma, Inc.
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce BLA resubmission for TX01(Neupogen Biosimilar)
August 15, 2022
Tanvex BioPharma : The Company has been required by TWSE to announce the financial data according to the regulations
August 4, 2022
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)(supplementary)
August 1, 2022
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)
July 31, 2022
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce that TX01(Neupogen Biosimilar) got Drug Establishment Licence from Health Canada
July 24, 2022
Research Tanvex Biopharma, Inc.
Tanvex Biopharma, Inc. company profile
View the public company page for Tanvex Biopharma, Inc. on 6ix.
Tanvex Biopharma, Inc. news
Read company news and market updates connected to Tanvex Biopharma, Inc..
Tanvex Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Tanvex Biopharma, Inc..